JPY 256600.0
(-0.77%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 13.2 Billion | 12.81 Billion | 10.99 Billion | 31.49 Billion | 19.62 Billion | 13.61 Billion |
Net Income | 9.51 Billion | 9.03 Billion | 8.03 Billion | 14.3 Billion | 8.88 Billion | 8.16 Billion |
Depreciation & Amortization | 3.82 Billion | 3.74 Billion | 3.78 Billion | 3.95 Billion | 3.95 Billion | 4.06 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -101.06 Million | -42.73 Million | -1.16 Billion | 4.78 Billion | -278.1 Million | 1.27 Billion |
Other non-cash items | -30.84 Million | 79.37 Million | 335.54 Million | 8.44 Billion | 7.05 Billion | 109.26 Million |
Investing Cash Flow | -18.15 Billion | -16.08 Billion | -6.11 Billion | -12.38 Billion | -9.22 Billion | -33.52 Billion |
Investments in PPE | -2.4 Billion | -16.63 Billion | -6.06 Billion | -12.35 Billion | -9.59 Billion | -33.66 Billion |
Acquisitions | - | - | -8.42 Million | - | - | - |
Investment purchases | - | -181.09 Million | -94.06 Million | -280.86 Million | -155.7 Million | -512.37 Million |
Sales/Maturities of investments | - | 637.41 Million | 64.42 Million | 182.07 Million | 416.98 Million | 558.29 Million |
Other Investing Activities | -15.74 Billion | 88.23 Million | -31.64 Million | 76.38 Million | 110 Million | 84.77 Million |
Financing Cash Flow | 4.23 Billion | 4.52 Billion | -13.25 Billion | -10.82 Billion | -11.37 Billion | 21.74 Billion |
Debt repayment | - | -18.5 Billion | -19.5 Billion | -12 Billion | -16.5 Billion | -10.5 Billion |
Dividends payments | -9.03 Billion | -8.75 Billion | -13.23 Billion | -8.8 Billion | -8.37 Billion | -7.72 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 13.27 Billion | 31.77 Billion | 19.48 Billion | 9.98 Billion | 13.5 Billion | 39.97 Billion |
Accounts receivables | -101.06 Million | -68 Million | -43.76 Million | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | 25.26 Million | -1.12 Billion | - | - | - |
Cash at beginning of period | - | 24.64 Billion | 33.68 Billion | 21.3 Billion | 26.31 Billion | 26.07 Billion |
Cash at end of period | -708.96 Million | 25.9 Billion | 25.29 Billion | 29.59 Billion | 25.33 Billion | 27.9 Billion |
Capital Expenditure | -2.4 Billion | -16.63 Billion | -6.06 Billion | -12.35 Billion | -9.59 Billion | -33.66 Billion |
Effect of forex changes on cash | - | 1000.00 | -12.92 Billion | -3000.00 | -1000.00 | 2000.00 |
Net cash flow / Change in cash | -708.96 Million | 1.25 Billion | -8.38 Billion | 8.28 Billion | -979.58 Million | 1.83 Billion |
Free Cash Flow | 10.8 Billion | -3.81 Billion | 4.92 Billion | 19.13 Billion | 10.02 Billion | -20.04 Billion |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2021 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.4 Billion | 2.4 Billion | 2.44 Billion | 9.51 Billion | 2.44 Billion | 9.03 Billion |
Depreciation & Amortization | 950.08 Million | 950.08 Million | 969.25 Million | 3.82 Billion | 969.25 Million | 3.74 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 19.75 Million | 19.75 Million | -33.54 Million | -101.06 Million | -33.54 Million | -42.73 Million |
Other non-cash items | 327.47 Million | 327.47 Million | 294.39 Million | -30.84 Million | 294.39 Million | 79.37 Million |
Investing Cash Flow | -282.8 Million | -282.8 Million | 7.92 Billion | -18.15 Billion | 7.92 Billion | -16.08 Billion |
Investments in PPE | - | - | - | -2.4 Billion | - | -16.63 Billion |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | -181.09 Million |
Sales/Maturities of investments | - | - | - | - | - | 637.41 Million |
Other Investing Activities | -282.8 Million | -282.8 Million | 7.92 Billion | -15.74 Billion | 7.92 Billion | 88.23 Million |
Financing Cash Flow | -2.44 Billion | -2.44 Billion | -4.43 Billion | 4.23 Billion | -4.43 Billion | 4.52 Billion |
Debt repayment | - | - | - | - | - | -18.5 Billion |
Dividends payments | -2.44 Billion | -2.44 Billion | -4.63 Billion | -9.03 Billion | - | -8.75 Billion |
Common Stock Repurchased | - | - | -4.15 Billion | - | -4.15 Billion | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 4.35 Billion | 13.27 Billion | -275.72 Million | 31.77 Billion |
Accounts receivables | 19.75 Million | 19.75 Million | -33.54 Million | -101.06 Million | -33.54 Million | -68 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | 25.26 Million |
Cash at beginning of period | - | - | - | - | - | 24.64 Billion |
Cash at end of period | 975.06 Million | 975.06 Million | 7.16 Billion | -708.96 Million | 7.16 Billion | 25.9 Billion |
Capital Expenditure | - | - | - | -2.4 Billion | - | -16.63 Billion |
Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
Net cash flow / Change in cash | 975.06 Million | 975.06 Million | 7.16 Billion | -708.96 Million | 7.16 Billion | 1.25 Billion |
Free Cash Flow | 3.7 Billion | 3.7 Billion | 3.67 Billion | 10.8 Billion | 3.67 Billion | -3.81 Billion |
002396
LRKKF
BPLPHARMA
M24
NTCIND
600983